The plasmin inhibitor, TA, has been proved to be effective in treatment of melasma with still unclear mechanisms, one study showed that tranexamic acid may also decrease VEGF and entothelin-1, both of which are responsible for increasing vascularity in affected lesions of melasma 28. The gene discussed is VEGFA; the disease is freckles.